Asia Pacific Non-invasive Aesthetic Treatment Market Size, Share & Industry Trends Analysis Report By End-Use (MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic), By Procedure, By Country and Growth Forecast, 2021-2027

The Asia Pacific Non-invasive Aesthetic Treatment Market is expected to witness market growth of 14.4% CAGR during the forecast period (2021-2027).

The chemical peel is an alternative to facials which has much better results. This is a non-invasive procedure that restrores luminosity stimulates skin renewal and refreshes the skin. Also, this is among the most cost effective types of skin resurfacing with minimal to no downtime depending upon the choice of peel. The aesthetic professionals provide controlled exfoliation of superficial layers of skin by the use of acids like lactic acid, salicylic acid & glycolic acid.

In addition, many skilled cosmetic surgeons are adopting laser technology for the treatment of damaged skin & help in improving pigmentation issues and reducing the size of the pores. The laser treatments such as non-ablative skin resurfacing targets deeper areas to enhance collagen production. This treatment uses technology that combines the treated & untreated skin areas resulting in a faster recovery period.

China is one among the largest provider of technologically advanced devices in different industries. The availability of new technologies for laser treatments such as longer wave length which may eliminate the risk of skin burning is influencing the people in the region to use these devices. In addition, the fashion & modeling industry of Hong Kong, China is growing which further attracts the people seeking career in this field towards non-invasive aesthetic treatments.

Moreover, the number of medical spas in the developing countries such as China, India, Thailand & South Korea is gradually increasing. According to the Office of the Registrar General & Census Commissioner, India, the number of people aged 45 to 64 in the region was around 13.5 % that is 139,166,661.

The China market dominated the Asia Pacific Non-invasive Aesthetic Treatment Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $9.3 billion by 2027. The Japan market is anticipated to grow at a CAGR of 13.7% during (2021 - 2027). Additionally, The India market is expected to showcase a CAGR of 15.1% during (2021 - 2027).

Based on End-Use, the market is segmented into MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic. Based on Procedure, the market is segmented into Injectables, Skin Rejuvenation, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Alma Lasers Ltd., Allergan PLC, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Johnson & Johnson, Candela Medical Corporation, Bausch Health Companies, Inc., Cutera, Inc., Lumenis Ltd., and Hologic, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End-use

• MedSpa
• Hospital/Surgery Center
• Traditional Spa
• HCP Owned Clinic

By Procedure

• Injectables
• Skin Rejuvenation
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Alma Lasers Ltd.
• Allergan PLC
• Galderma S.A.
• Merz Pharma GmbH & Co. KGaA
• Johnson & Johnson
• Candela Medical Corporation
• Bausch Health Companies, Inc.
• Cutera, Inc.
• Lumenis Ltd.
• Hologic, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free